Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
Diabetes DiscourseAddressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
John W. Ostrominski, MD, MPH
Enhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Diabetes DiscourseEnhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Laura Chiavaroli, PhD
Investigating Beta Cell Dysfunction and Immune Activity in Early T1D
Diabetes DiscourseInvestigating Beta Cell Dysfunction and Immune Activity in Early T1D
Edward Phelps, PhD
Investigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Diabetes DiscourseInvestigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Vira Kravets, PhD
Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Diabetes DiscourseUnanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Edward Phelps, PhD
Assessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
On the Frontlines of PsoriasisAssessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
Mary Leuchars, MD
Jeffrey Cohen, MD, MPH
- advertisement
- 3 questions
- advertisement
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
- 10/15/2026
- 10/06/2026
- 10/05/2026
- 10/01/2026
- 10/01/2026